Asset Details
Do you wish to reserve the book?
Meeting Report: 3.sup.rd .sup.International Workshop on Insulin Cancer Heidelberg, Germany, October 30-31, 2010
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Meeting Report: 3.sup.rd .sup.International Workshop on Insulin Cancer Heidelberg, Germany, October 30-31, 2010
Do you wish to request the book?
Meeting Report: 3.sup.rd .sup.International Workshop on Insulin Cancer Heidelberg, Germany, October 30-31, 2010
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Meeting Report: 3.sup.rd .sup.International Workshop on Insulin Cancer Heidelberg, Germany, October 30-31, 2010
2010
Overview
The 3rd International Workshop on Insulin and Cancer was held on October 30-31, 2010 at the German Cancer Research Centre in Heidelberg/Germany. The topics followed-up the discussions of the previous workshops: possible differences in mitogenicity between natural insulin and genetically engineered insulin derivatives (insulin analogues), as shown by laboratory studies and epidemiologic studies alike; molecular studies on the links between metabolic and mitogenic effects of insulin, and of hyperinsulinaemia in particular; epidemiologic evidence of interferences between insulin and other hormones, particularly sex hormones, and obesity-associated cancer; the involvement of inflammatory cytokines produced by fat tissue in obesity-associated cancer; aspects of drug-design (binding drugs to albumin) and, last but not least, detection and investigation of circulating cancer cells.
Publisher
BioMed Central Ltd
Subject
